Latest Diabetes: Type II news
AI Diabetes Prevention Program Yields Similar Results as Human-Led Program
posted November 13th
by modernClinician Editorial Team
by modernClinician Editorial Team
AHA: GLP-1 Receptor Agonists Not Linked to Pancreatitis in Adults With High Triglycerides
posted November 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
GI Safety Profile Similar for Dulaglutide, Semaglutide, Tirzepatide
posted November 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
AHA: Optimal Heart Health Linked to Reduced MCI Risk in Type 2 Diabetes
posted November 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes 
Type 2 Diabetes Linked to Worse Menopausal Symptoms 
Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD .jpg)
Semaglutide Not Linked to Higher Neovascular Age-Related Macular Degeneration Risk Related Articles
AHA: Consuming Up to 400 mg/Day of Caffeine Safe for Most Adults 
GLP-1 Receptor Agonist Use Linked to Higher Risk for Ischemic Optic Neuropathy 
GLP-1 Receptor Agonists Linked to Lower Mortality, Amputation Rate in PAD and Type 2 Diabetes Monthly Specialist Briefings
Stay Connected
